4//SEC Filing
Belsky Marc 4
Accession 0001415889-25-001367
CIK 0001645666other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:15 PM ET
Size
5.5 KB
Accession
0001415889-25-001367
Insider Transaction Report
Form 4
Belsky Marc
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-09+24,500→ 24,500 totalExercise: $6.58Exp: 2035-01-08→ Common Stock (24,500 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on February 9, 2025, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001382629
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:15 PM ET
- Size
- 5.5 KB